Services on Demand
- Cited by SciELO
- Access statistics
Print version ISSN 0213-9111
Gac Sanit vol.21 n.4 Barcelona Jul./Aug. 2007
Inconsistent condom use among socially excluded heroin users
Uso inconsistente del condón en los usuarios de heroina en situación de exclusión social
Joan Carles March, Eugenia Oviedo-Joekes, Manuel Romero
Escuela Andaluza de Salud Pública, Granada, España.
This research has been financed by European Union funds (SI2100675/99CVF4-009).
El objetivo del presente trabajo es analizar las conductas sexuales entre los usuarios de heroína, en situación de exclusión social, y conocer los factores asociados al uso inconsistente del condón en sus relaciones sexuales (coito vaginal) con parejas ocasionales y estables. Los datos fueron recogidos en las ciudades de Granada y de Sevilla entre julio y octubre de 2000, a través de un cuestionario estructurado, a 391 participantes. El 22 y el 15% de los participantes han hecho un uso consistente del condón durante el último año con sus parejas ocasionales y estables, respectivamente. Se ha encontrado una mayor probabilidad de un uso inconsistente del condón con las parejas ocasionales entre usuarios que habían practicado el sexo oral, y que desconocen si su(s) pareja(s) se inyecta drogas. En cuanto a las parejas estables, las que se inyectan y no hablan de sida entre ellos mostraron una probabilidad más alta de no utilizar consistentemente el condón. Para ambos grupos, cuando la pareja es quien siempre propone el uso del condón, el riesgo de no utilizarlo es de 4 veces más que cuando son ellos mismos quienes proponen su uso. Hablar sobre condones y sida con los amigos, las parejas y la familia, así como aprender a negociar el uso del condón, parecen ser las estrategias más apropiadas para el abordaje de esta población, de cara a promover un sexo protegido dentro del sistema sociosanitario.
Palabras clave: Heroína. Condón masculino. Conducta sexual. Reducción de daños.
The study focused in sexual behaviour among socially excluded heroin users, identifying factors associated with inconsistent condom use. Data was collected in the cities of Granada and Seville between July and October 2000, through a structured questionnaire, to 391 participants. Twenty two and 15% of participants have made consistent use of condoms in vaginal sex in the last year with occasional and regular partners respectively. There is a greater likelihood of inconsistent condom use with occasional partners among users who had had oral sex, and who does not know if their partner(s) inject or injected drugs. For regular partners those who have an injecting partner and do not speak with their sexual partners about AIDS have a higher probability to do not use always a condom. For both groups, when always the partner is who propose the use of condoms (when used) and not themselves, the risk not to use it is near 4 times more than when thems elves propose to use it. Speaking about condoms and AIDS with mate, partners and family, and learning to negotiate the use of condoms seems to be the most important strategies to be approached for this sample, from the social and health care system in order to promote a protected sex.
Key words: Heroin users. Male condom. Sexual behaviour. Harm reduction.
The consistent, correct use of condoms is an effective means of preventing sexual transmission of the human immunodeficiency virus (HIV)1. For this reason, increased condom use has become a key intervention aimed at protecting people from HIV infection both for more vulnerable groups as well as the general population2. Drug misusers comprise one of these vulnerable groups, given that they may behave in ways that put them at risk for HIV-infection, whether directly or indirectly related to their addiction. Intravenous drug users (IDUs) are the focus of healthcare interventions aimed at reducing risk behaviour associated with drug-abuse (e.g., needle-sharing), which have achieved positive changes towards less harmful3,4. Nevertheless, it would appear that IDUs are more easily convinced to stop sharing needles than to modify their sexual habits5. Several studies indicate that a large proportion of drug addicts use condoms inconsistently6 depending upon the type of sexual partner; for instance, there is less frequent use in steady couples than in occasional partners7,8 and more widespread use in the case of sexual workers' clients9,10. Even though modifying behaviours that make people more susceptible to infections would seem to be a relatively simple strategy, the circumstances under which intervention must be implemented are complex and require multi-dimensional approaches2. The complexity of the approach is self-evident in the case of socially excluded illicit-drug users, while the need for HIV-prevention strategies adapted to this population must also be met in the short term.
In recent years, intravenous heroin addicts in Andalusia have become a minority as inhalation has replaced injection as the main route of administration, and heroin is mainly taken mixed with cocaine (speedball)11,12. Some studies in Spain have described condom use among intravenous illicit-drug users7,8,13,14, mainly in view of the fact that 65% of AIDS cases in our country occurs IDUs15. Although there is a lesser risk of infection associated with heroin chasing16,17, sexual transmission is not changed in any way by this. Even when the incidence of HIV infections among IDU's have being descending in the last decade, Spain still is one of the European countries with the greater prevalence of HIV related to intravenous drug use18. From this point of view, drug users who carry out unprotected sex are exposed to transmit and contract this sexually transmitted disease at a higher risk than the general population. This means that drug users are a vulnerable population that requires specific approach in order to prevent infections and reinfections.
The present study aims to examine sexual behaviour, among socially excluded heroin users, and to identify factors associated with the use of condoms.
Subjects and methods
This study on drugs and social exclusion was conducted on a sample group of 391 participants from Seville, Granada in the frame of a large European study that involved other eight cities. Material and methods were published elsewhere, as well as other characteristics of the participants and the study19-21.
Participants were recruited from widely dispersed sampling points in both cities to gain maximum coverage of key zones for this population. The criteria for inclusion in the study were presence at regular gathering places for marginal, illegal drug users having consumed heroin or cocaine in the last 12 months. Interviews took place on streets, squares and other places previously identified and mapped out by the outreach team.
Data was collected in structured, face-to-face interviews lasting approximately 60 minutes, using a World Health Organisation questionnaire adapted to our sample population on the risk of HIV infection and drug injection22,23. The questionnaire also included socio-demographic items, and indicators of marginalisation. All the questions on specific behaviours (i.e. drug use, have sex, have used condoms, etc.) are referred to the last 12 months.
The fieldwork was carried out in the cities of Granada and Seville between July and October 2000. In this study, since social exclusion refers to the context, we went in search of either marginalised areas (specific neighbourhoods) or areas in which the most marginalised drug users gather (soup kitchens, shooting galleries) to consume, buy drugs or get drug money. Interviews were conducted by street educators with the help of «peers»3,7,24-27. This strategy was combined with snowball sampling. Since the intention of the whole study was a description of the situation of marginalized drug users, no sample size calculation was planned under statistical methods. Each research partner interviewed near 200 persons, given that the teams evaluated that number as enough to achieve the information that we were looking for.
Fieldwork included the interview, as well as the distribution of material means (syringes and/or condoms) and general information on prevention and harm-reduction related to the transmission of infectious diseases, drug use and safe sex.
The sample group's characteristics were examined against the variables of interest through descriptive analysis. This initial analysis dealt with the total group of heroin-users. The dependent variable -frequency of condom use in vaginal sex with occasional partners and regular partners- originally consisted of 5 categories, which were later combined into two: consistent use of condom (always), and inconsistent use (not always). These two levels chosen for the dependent variable are based on the premise that any frequency of condom use other than «always» may be a cause for healthcare intervention. Vaginal sex as dependent variable was chosen given that this is the more frequent sexual intercourse among this sample (94%), and that less than 3% are homosexual/bisexual males. Bivariate analyses (chi square) were performed for all the variables evaluated, comparing participants who consistently use condoms with those who do not for each kind of partner's relationship in the last 12 month: regular and occasional. Two binary logistic regression analysis was performed in order to examine the probability of inconsistent condom use in vaginal sex with occasional and regular partners. The regression models were performed with the significant variables (p = 0.05) from the bi-varied analysis in two steps. Gender, age and city were introduced into the regression analysis as control variables, despite their significance, given that gender stereotypes, stage in life and environmental factors might be associated with condom use. The ensuing block introduced all the variables using a (manually) a back step method. Those variables with a significance of less than 0.1 were excluded from the model in the second step.
Table 1 shows the principal characteristics of the target group, where the majority were over 32 years old (55.8%) and were male (83.3%). High percentages can be observed for some marginality indicators, such as daily heroin consumption in nearly 90% of participants and more than half (57.6%) having served time in prison. The prevalence of self reported disease ranges between 30.8% (HIV) and 44.8% (Hepatitis C). The percentage of participants who had had sex with regular and occasional partners in the last 12 months are 50.4% and 42.7% (13% of them had had sex with both kind of partners). Sexual orientation of the sample is almost totally heterosexual (97.4%).
Table 2 describes sexual behaviour and condom use in relations with casual and regular partners. The most practiced sex was vaginal (94%), for both groups. The proportion of consistent condom use with occasional partners is 22.3 and 14.8% with regular partners. Consistent use of condoms in terms of oral and anal sex is also higher with occasional partners than with stable partners. The main reasons cited for not using a condom with occasional partners are reduced sensitivity or plea-sure in sexual relations associated with condoms and trusting or knowing the partner. Also, 23.9% cite not having access to condoms. For regular partners, the main reason to do not use condoms are that both are HIV+ and to use other form of contraception. The main reason for condom use varies between occasional and regular partners, with 59.2% of occasional sexual partners stating avoidance of infection as the reason, while 64.1% in stable partners use condoms to avoid pregnancies. More than one third of participants who have had sexual relations with occasional or regular partners acknowledge having used condoms less frequently under the effects of alcohol or drugs. Finally, 23.4% of the partners in occasional relations were intravenous drug-users, compared to 19.8% in regular relations.
Comparisons with significant differences between participants who consistently use condoms during vaginal sex and those who do not are shown in table 3, for occasional partners and in table 4 for regular partners. For both groups, those participants in Granada, who have not ever been in drug treatment, ever had sexually transmitted diseases, have had oral sex in the last year, do not use condoms more frequently because of AIDS, for whom the main reason to use condom in not prevent possible infections and who do not speak frequently about AIDS or condom use with their family, friends or sexual partner show a higher percentage of inconsistency condom use. Those who usually propose the use of condoms to their sexual partners show higher percentages of consistent condom use. Participants who have had sexual relationship with occasional partners showed also significant differences in other variables. Those aged 31 or younger, hepatitis C positive, who had carried out anal sex, and had not reduced the number of sexual partners, or stop injecting or injected less since hearing about AIDS present higher percentages of inconsistent condom use. Those who does not know if their occasional partner in the last 12 months injected drugs show higher percentage of inconsistent condom use. This situation differs from regular partners, where none of them said that did not know, and those who their partners did not injected presented higher percentages of consistent condom use.
Table 5 shows the two logistic regression models for the probability of condom use during vaginal sex with occasional and regular partners: always vs. not always No correlations between condom use and indicators of both marginality and health can be found within this models. For both groups, participants from Seville have a lesser probability of inconsistent condom use than those from Granada. A greater probability to do not use always a condom with occasional partners are for those participants who had had oral sex, and who does not know if their partner(s) inject drugs currently or in the past. When always the partner is who propose the use of condoms (when used) and not their selves, the risk to do not use it is almost 6 more times. For regular partners we found the same pattern for this variable, with an OR of 4.83, however not statistically significant (p = 0.093). For this group, does who have a IDU or former IDU partner and do not speak with their sexual partners about AIDS have 9 and 4.5 more times of probability, respectively, to do not use always a condom. The Hosmer-Lemeshow goodness of fit test was not significant in any of the models.
The present study has examined sexual behaviour and practices associated with risk of HIV-infection among socially excluded heroin users, mainly chasers. Among the results we found a low percentage of participants who claim to have made consistent use of condoms in vaginal sex with occasional partners (22.3%), not only in absolute terms, but also in comparison with other studies in Spain on opioid dependent persons (around 40%7,8,28 and with the general population in Andalusia 57.8%29). In addition, as in other studies, condom use was less frequent among regular partners than with occasional partners7,8.
We found a positive association of condom use with drug-treatment. This could stem from contact with health services and the interventions they recommend to patients, although this association disappear after adjusted for other variables. It may be assumed that patients under drug treatment have received advice and support from health professionals regarding harm reduction associated with drug-use and HIV-infection30. The integration of heroin addicts into the healthcare network is, and must continue to be, one of the central objectives in Public Health policies, adapting the available treatments to this specific population's characteristics and needs, not only to treat the addiction, but also to work towards harm reduction and focus on the problems associated with drug use.
Half of the participants in this study admit to assessing the looks of partners (occasional) as a strategy for deciding whether or not to wear a condom. This strategy is in contrast with the fact that a large majority of these participants believe that one can «look alright» and yet still be an HIV-carrier. In a qualitative study on alternative strategies to condom use among drug-users, considering one's partner to be «clean and decent» is believed to be a way of reducing the risk of infection5. Such assessment of appearance may be based on indicators unrelated to HIV, although an indirect relationship is assumed. Therefore, it could be that trust in one's partner based on appearance may not be so much what that appearance reveals about being an AIDS-carrier, but rather about whether the person is perceived to be reliable in general, conferring a degree of credibility on his or her words and actions. Understanding the nature of relationships and how they work allows us to adapt interventions and formulate healthcare messages related to recipients' perceptions31,32. These results suggest [the need for] a point of intervention which addresses the fact that a person may be an HIV-carrier and not know it (nearly 20% of this sample group did not know if was HIV positive), which would in turn foster a more active role in decision-making based on users' own arguments.
Talking about AIDS and condom with mates, friends and partners is associated with having protected sex. Using a condom requires a certain degree of planning, at least having one on hand when the need arises; this contrasts with the characteristic compulsiveness of opiate addicts, driven by the daily need to get their dose33. In Andalusia condoms can be easily obtained without charge in a lot of social and health care resources (i.e. non governmental associations; public service of sexuality counselling), but even this can be out of the daily route of a drug dependent person. Talking about AIDS and condom use is a healthy strategy, not only for sharing perceptions and opinions on the subject, but to help in the planning of what to do and how to go about it. This study once again brings into focus the relevance of using peer groups in harm-reduction strategies7, and to reach them through any health or social services and try to 'talk' about that. If talking with friends and partners about condoms can influence their use, then working directly with such peer groups may be an effective way to get the message across. Nevertheless, in the multivariate model, only for stable partners, speak with them about AIDS remain significant.
One of the most consistent associations among regular and also occasional sexual (vaginal) relations that distinguish between those who always had had protected sex in the last 12 months (than those who did not) was: who propose to use condoms. When the decision to wear a condom relies on the partner, the participants have a higher probability (five more times) to may be not using it. This association has being shown in other studies34-37. For example, Harvey et al34 found that condom use were higher among women who reported hat they make decisions about using condoms alone or with their partner as compared to those who reported that their partner makes those decisions. Probably who hold the power in a relationship will make the decision of use or not a condom36. Nevertheless, to have protected sex depends on the ability to negotiate the use of condoms37, skills that can be developed.
The choice to use a condom does not depend solely on the person's predisposition to do so, but rather depends on social factors and their impact on decision making32. This would imply that our intervention strategies must be based upon the needs and characteristics of the target population and planned accordingly from within, alongside and for that population. This study highlights the importance of making the widest possible array of treatment options available, adaptable to the profiles of drug addicts. This will enable them to be in contact with the social and health network and to take an active part in intervention strategies targeting them and their groups. Speak about condoms and AIDS with mate, partners and family; and learn to negotiate the use of condoms seams to be the most important strategies to be approached for this sample, from the social and health care system in order to promote a protected sex.
Despite the several limitations, this study sheds light on sexual behaviour associated in a population ordinarily difficult to access, making way for improvements in intervention policies aimed at prevention.
The authors would like to thank Almudena Moreno (Asociación Hogar 20, Granada, Spain) and Carolina Junco (Asociación Colectivo La Calle, Seville, Spain).
1. UNAIDS. The male latex condom. Genève: WHO; 2002. [ Links ]
2. Bonnel C, Imrie J. Behavioural interventions to preven HIV infection: rapid evolution, increasing rigour, moderate success. In: Weiss RA, Adler MA, Rowland-Jones SL, editors. The changing face of HIV and AIDS. Oxford: Oxford University Press, 2001. p 155-70. [ Links ]
3. Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep. 1998;113 Suppl 1:170-81. [ Links ]
4. Cox GM, Lawless MC, Cassin SP, Geoghegan TW. Syringe exchanges: a public health response to problem drug use. Ir Med J. 2000;93:143-6. [ Links ]
5. Metsch LR, McCoy CB, Wingerd J, Miles CC. Alternative strategies for sexual risk reduction used by active drug users. AIDS Behav. 2001;5:75-84. [ Links ]
6. Booth RE, Kwiatkowski CF, Chitwood DD. Sex related HIV risk behaviors: differential risks among injection drug users, crack smokers, and injection drug users who smoke crack. Drug Alcohol Depend. 2000;58:219-26. [ Links ]
7. Romero M, Zunzunegui MV, Perea E, Gornemann I, Fernández A. Uso consistente del condón entre los usuarios de droga por vía intravenosa y sus parejas estables. Gac Sanit. 1999; 13:96-101. [ Links ]
8. Pérez González K, Domingo-Salvany A, Hartnoll R. Prevalencia de la infección por el virus de la inmunodeficiencia humana y conductas de riesgo en consumidores de opioides visitados en un servicio de urgencias. Gac Sanit. 1999;13:7-15. [ Links ]
9. Estébanez P, Sarasqueta C, Fitch K, Zunzunegui V, Contreras G, Valera JM, et al. Prevalencia de VIH-1 y otras enfermedades de transmisión sexual entre prostitutas españolas. Med Clin (Barc). 1992;99:161-7. [ Links ]
10. García de la Hera M, Fernández García E, Hernández-Aguado I, Vioque J. Cambios en el uso del preservativo en una cohorte de prostitutas. Gac Sanit. 2001;15:209-16. [ Links ]
11. March JC, Oviedo-Joekes E, Romero M, Sánchez-Cantalejo E. Factores asociados al consumo de heroína inhalada e intravenosa. Rev Esp Salud Pública. 2005;79:391-401. [ Links ]
12. Junta de Andalucía. Los andaluces ante las drogas VIII. Sevilla: Junta de Andalucía, Comisionado para la Droga, 2004. [ Links ]
13. Bravo Portela MJ, Barrio Anta G, De la Fuente de Hoz L, Colomo Gómez C, Royuela Morales L, Estébanez Estébanez P. Conductas de riesgo para transmisión del VIH entre los usuarios recientes de un programa de intercambio de jeringas en Madrid, 1993. Gac Sanit. 1996;10:261-73. [ Links ]
14. Bravo MJ, Barrio G, De la Fuente L, Colomo C, Royuela L. Persistencia de conductas de riesgo para la transmisión del VIH en inyectores de drogas de Madrid, Sevilla y Valencia. Grupo de Trabajo de Médicos del Mundo para la monitorización de la infección por el VIH y las prácticas de riesgo en inyectores de drogas. Gac Sanit. 1999;13:109-18. [ Links ]
15. Instituto Nacional de Estadística. Casos de sida. Actualización a 30 de junio de 2003 por CCAA/provincia de residencia y categoría de transmisión. 2004. [ Links ]
16. Esteban J, Gimeno C, Aragonés A, Barril J, Pellín M. Prevalencia de infección por el virus de la inmunodeficiencia humana y hepatitis C en una cohorte de pacientes en tratamiento de mantenimiento con metadona. Med Clin (Barc). 2003; 120:765-7. [ Links ]
17. Torres-Tortosa M, Ruiz López de Tejada MR, Fernández-Elías M, Pérez-Pérez C, Fernández-Conejero E, Ugarte I, et al. Cambios en la vía de administración de la heroína y frecuencia de infección por el virus de la inmunodeficiencia humana. Med Clin (Barc). 1995;104:249-52. [ Links ]
18. Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18:2295-303. [ Links ]
19. March JC, Oviedo-Joekes E, Romero M. Drugs and social exclusion in ten European cities. Eur Addict Res. 2006;12:33-41. [ Links ]
20. March JC, Oviedo-Joekes E, Romero M. Factors associated to reported hepatitis C and HIV among injecting drug users in ten European cities. Enferm Infecc Microbiol Clin. 2007; 25:91-7. [ Links ]
21. March JC, Oviedo-Joekes E, Romero M. Injection and non-injection drug use related to social exclusion indicators in two Andalusian cities. Drugs: Educ Prev Policy. 2005;12: 437-47. [ Links ]
22. WHO Collaborative Study Group. An international comparative study of HIV prevalence and risk behaviour among drug injectors in 13 cities. Bull Narc. 1993;45:19-45. [ Links ]
23. Zunzunegui Pastor MV, Rodríguez Arenas MA, Sarasqueta Eizaguirre C. Drogadicción intravenosa y riesgo de infección por del VIH en Madrid 1990. Gac Sanit. 1993;7:2-11. [ Links ]
24. Griffiths P, Gossop M, Powis B, Strang J. Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction. 1993;88:1617-26. [ Links ]
25. Kuebler D, Hausser D. The Swiss Hidden Population Study: practical and methodological aspects of data collection by privileged access interviewers. Addiction. 1997;92:325-34. [ Links ]
26. Cottler LB, Compton WM, Ben Abdallah A, Cunningham-Williams R, Abram F, Fichtenbaum C, et al. Peer-delivered interventions reduce HIV risk behaviors among out-of- treatment drug abusers. Public Health Rep. 1998;113 Suppl 1: 31-41. [ Links ]
27. March JC, Oviedo-Joekes E, Romero M, Gómez M, Rodríguez S, León MI, et al. El proceso de captación de los participantes en el programa experimental de prescripción de estupefacientes en Andalucía (PEPSA). Gac Sanit. 2004; 18:245-7. [ Links ]
28. Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, et al. Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse. 2004;39:1353-68. [ Links ]
29. Madrid: Instituto Nacional de Estadística; 2005. Encuesta de salud y hábitos sexuales 2003. Personas que han tenido parejas ocasionales en el último año por sexo, Comunidad Autónoma y uso de preservativo con parejas ocasionales. [ Links ]
30. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep. 1998; 113 Suppl 1:107-15. [ Links ]
31. Sherman SG, Latkin CA. Intimate relationship characteristics associated with condom use among drug users and their sex partners: a multilevel analysis. Drug Alcohol Depend. 2001; 64:97-104. [ Links ]
32. Rhodes T, Quirk A. Drug users' sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management. Soc Sci Med. 1998;46:157-69. [ Links ]
33. Albertin-Carbo P, Domingo-Salvany A, Hartnoll RL. Psychosocial considerations for the prevention of HIV infection in injecting drug users. Qual Health Res. 2001;11:26-39. [ Links ]
34. Harvey SM, Bird ST, Galavotti C, Duncan EA, Greenberg D. Relationship power, sexual decision making and condom use among women at risk for HIV/STDS. Women Health. 2002; 36:69-84. [ Links ]
35. Semaan S, Lauby J, O'Connell AA, Cohen A. Factors associated with perceptions of, and decisional balance for, condom use with main partner among women at risk for HIV infection. Women Health. 2003;37:53-69. [ Links ]
36. Tschann JM, Adler NE, Millstein SG, Gurvey JE, Ellen JM. Relative power between sexual partners and condom use among adolescents. J Adolesc Health. 2002;31:17-25. [ Links ]
37. Soler H, Quadagno D, Sly DF, Riehman KS, Eberstein IW, Harrison DF. Relationship dynamics, ethnicity and condom use among low-income women. Fam Plann Perspect. 2000; 32:82-8, 101. [ Links ]
38. Rounsaville BJ. Rationale and guidelines for using comparable measures to evaluate substance abusers: an overview. En: Rounsaville BJ, Tims FM, Horton AM, Sowder BJ, editors. Diagnostic source book on drug abuse research and treatment. Rockville: US Department of Health and Human Services; 1993. p. 1-10. [ Links ]
39. Domingo-Salvany A, Hartnoll RL, Maguire A, Suelves JM, Anto JM. Use of capture-recapture to estimate the prevalence of opiate addiction in Barcelona, Spain, 1989. Am J Epidemiol. 1995;141:567-74. [ Links ]
Dirección para correspondence:
Escuela Andaluza de Salud Pública.
Cuesta del Observatorio, 4. Campus Universitario de Cartuja.
18080 Granada. España.
Received: August 22, 2006.
Accepted: March 21, 2007.